Clinical Scenario #5: Applying Biomarkers in Biliary Tract Cancers |
0.75 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
What Drives Reimbursement for Biomarker Testing? |
1.25 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
NCCN Guidelines® Insights - Breast Cancer, Version 4.2023 |
1.00 |
06/10/2023 - 12:00am to 06/10/2024 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: The Role of PD-L1 Therapy in the Early Treatment of Triple Negative Breast Cancer |
1.00 |
06/09/2023 - 12:00am to 05/31/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Neoadjuvant and Adjuvant Therapy for Patients with Resectable Early-Stage and Locally Advanced Non-Small Cell... |
1.00 |
05/26/2023 - 12:00am to 05/26/2024 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Changing Treatment Paradigms in Chronic Lymphocytic Leukemia |
1.00 |
05/26/2023 - 12:00am to 05/24/2024 - 12:00am |
NCCN Guidelines® Insights - Distress Management, Version 2.2023 |
1.00 |
05/10/2023 - 12:00am to 05/10/2024 - 12:00am |
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Breast Cancer |
0.50 |
05/03/2023 - 12:00am to 03/31/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Relapsed/Refractory Mantle Cell Lymphoma |
1.00 |
04/26/2023 - 12:00am to 04/26/2024 - 12:00am |
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Prostate Cancer |
0.50 |
04/26/2023 - 12:00am to 03/31/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Uveal Melanoma: Treatment of Metastatic Disease |
1.00 |
04/17/2023 - 12:00am to 04/17/2024 - 12:00am |
NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 2.2023 |
1.00 |
04/10/2023 - 12:00am to 04/10/2024 - 12:00am |
Recognizing Bias and Health Care Disparities in Black Patients |
0.25 |
03/31/2023 - 12:00am to 03/31/2024 - 12:00am |
Diagnosis and Management of Breast Cancer: What does the Evidence Show, What are We Doing, And What’s on the Horizon? |
0.75 |
03/31/2023 - 12:00am to 03/31/2024 - 12:00am |
Prostate Cancer in Black Individuals: How Can We Do Better? |
0.50 |
03/31/2023 - 12:00am to 03/31/2024 - 12:00am |